Probability of success in this context is a model‑generated estimate that a clinical trial, or a drug progressing between phases, will meet its predefined goals. This differs from traditional p‑values or power calculations, and understanding the distinction is key when interpreting AI‑driven PoS dashboards used for portfolio decisions, site selection or trial continuation versus termination choices.